110 related articles for article (PubMed ID: 631030)
21. [Treatment of cerebral circulatory insufficiency. Double-blind study of the efficacy of a quinine-papaverine combination].
Klemm J
Fortschr Med; 1984 Oct; 102(39):1000-2. PubMed ID: 6389288
[TBL] [Abstract][Full Text] [Related]
22. Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements.
Knezevic S; Mubrin Z; Risberg J; Vucinic G; Spilich G; Gubarev N; Wannenmacher W
Int Clin Psychopharmacol; 1989 Jan; 4(1):25-38. PubMed ID: 2687355
[TBL] [Abstract][Full Text] [Related]
23. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
Rao DB; Norris JR
Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
[No Abstract] [Full Text] [Related]
24. [The use of Ergocomb in symptoms of cerebrovascular insufficiency].
Pöthig D; Sauer I; Hansen H; Weidnitzer M
Z Alternsforsch; 1983; 38(6):443-9. PubMed ID: 6659572
[TBL] [Abstract][Full Text] [Related]
25. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
Calisti G; Biscarini L; Miseo A
Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
[No Abstract] [Full Text] [Related]
26. Treatment of chronic cerebrovascular disease in elderly patients with pentoxifylline.
Blume J; Rùhlmann KU; de la Haye R; Rettig K
J Med; 1992; 23(6):417-32. PubMed ID: 1293252
[TBL] [Abstract][Full Text] [Related]
27. [Effect of Ouabain on cerebral blood flow (author's transl)].
Heiss WD; Reisner T; Reisner H; Havelec L; Kubicek F; Dietmann K
Wien Klin Wochenschr; 1976 Mar; 88(5):171-4. PubMed ID: 973377
[TBL] [Abstract][Full Text] [Related]
28. [Dihydroergotoxine mesylate in the treatment of senile cerebral insufficiency. Result of a long-term multicenter double-blind clinical trial with a placebo].
Lazzari R; Passeri M; Chierichetti SM
Presse Med; 1983 Dec; 12(48):3179-85. PubMed ID: 6228938
[TBL] [Abstract][Full Text] [Related]
29. [Vascular-induced disorders of cerebral performance in the elderly. Long-term therapy with pentoxifylline and psychological mental training].
Blume J; Rühlmann KU; de la Haye R; Rettig K; Oltmer G
Fortschr Med; 1990 Nov; 108(33):638-42. PubMed ID: 2127040
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
Kellner H
MMW Munch Med Wochenschr; 1976 Oct; 118(43):1399-1402. PubMed ID: 825745
[TBL] [Abstract][Full Text] [Related]
31. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
Matejcek M; Knor K; Piguet PV; Weil C
J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
[TBL] [Abstract][Full Text] [Related]
32. [Cerebral blood flow and social prognosis after cerebrovascular ischaemia (author's transl)].
Heiss WD; Zeiler K; Havelec L
Dtsch Med Wochenschr; 1978 Apr; 103(14):597-702. PubMed ID: 639693
[TBL] [Abstract][Full Text] [Related]
33. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
[TBL] [Abstract][Full Text] [Related]
34. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
Schenker H
Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
[No Abstract] [Full Text] [Related]
36. [Controlled study of the effect of dihydroergocristine on organic brain psychosyndrome].
Aranda B; Dumoulin P; Groothold G
Arzneimittelforschung; 1992 Nov; 42(11A):1406-9. PubMed ID: 1492863
[TBL] [Abstract][Full Text] [Related]
37. Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly.
Gross RJ; Eisdorfer CE; Schiller HS; Cox G
Exp Aging Res; 1979 Aug; 5(4):293-302. PubMed ID: 520386
[TBL] [Abstract][Full Text] [Related]
38. The clinical assessment of brain failure in the elderly.
McConnachie RW
Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464
[TBL] [Abstract][Full Text] [Related]
39. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
Nobuhara K
Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168
[TBL] [Abstract][Full Text] [Related]
40. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
Bardin P; Campo R
Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
